Welcome to the iCAD Investors Page

iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The core business delivers innovative cancer detection and radiation therapy  solutions and services that enable clinicians to find and treat cancers earlier and  while enhancing patient care. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection (CAD) and radiation therapy (eBx) treatments.

The company's common stock is listed on the NASDAQ Stock Market under the symbol "ICAD".

Featured Financial Press Releases

August 8, 2017
iCAD Reports Second Quarter 2017 Financial Results And Announces $13 Million Credit Facility With Silicon Valley Bank
Read More
View Webcast

August 1, 2017
iCAD to Present at the Canaccord Genuity 37th Annual Growth Conference
Read More
View Webcast

July 31, 2017
iCAD To Report Second Quarter 2017 Financial Results On Tuesday, August 8
Read More
View Webcast

May 22, 2017
iCAD To Participate In Two Upcoming Investor Conferences
Read More

* See all Financial Press Releases

Featured Events and Webcasts

Quick Links

Investor Relations

LifeSci Advisors

Bob Yedid,
646-597-6989

Bob@lifesciadvisors.com

Media Inquiries

Berry & Company Public Relations, LLC

Lynn Granito

+1 212-253-8881

icad@berrypr.com

CAD is committed to corporate sustainability and to making a difference for our environment.

iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and while enhancing patient care. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers.

Facebook Twitter LinkedIn

© 2017, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo and Never Stop Looking is a trademark of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.